ACAT-IN-8
ACAT-IN-8 (example 206) is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. ACAT-IN-8 inhibits NF-κB mediated transcription[1].
Product Specifications
CAS Number
199984-35-5
UNSPSC
12352005
Target
Acyltransferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/acat-in-8.html
Solubility
10 mM in DMSO
Smiles
O=S(OC1=C(C(C)C)C=C(NC([C@H](N)C)=O)C=C1C(C)C)(NC(CC2=C(C(C)C)C=C(C(C)C)C=C2C(C)C)=O)=O
Molecular Formula
C32H49N3O5S
Molecular Weight
587.81
References & Citations
[1]Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62091R-FITC-TR 20 µL
PSMA2 Recombinant Antibody, FITC Conjugated
Sign In for Pricing
View Details 